Fundraising Fox7wire Ventures — 2021 Investments
6 investments dated 2021 · listed companies and verified rows first · show all
NOCD provides specialized treatment for obsessive-compulsive disorder through live video sessions with OCD-trained therapists and 24/7 in-app support between sessions, using exposure and response prevention (ERP) therapy.
Digital HealthHealthtechMental HealthChicago, US
LARRY TRUSKY(Executive Officer)inStephen Smith(Cofounder)in
Board seatGlen Tullman· per SEC Form D
Co-investorsChicago VenturesCorewell Health VenturesF-Prime CapitalKaiser Permanente VenturesLongitude CapitalMeridian Street Capital+3 more
MedArrive provides software for scheduling, routing, and real-time tracking of in-home care delivery teams.
HealthtechLogistics & Supply ChainSaaSNew York, US
Inna Plumb(Executive Officer)inDaniel Trigub(Executive Officer, Director)
BoardWilliam Sullivan(Director)Annie Case(Director)inAndy Harrison(Director)Agneta Breitenstein(Director)in
Co-investorsCobalt VenturesCorewell Health VenturesDeclaration PartnersKleiner PerkinsDefine VenturesLeaps by Bayer+2 more
OM1 develops AI-powered analytics and data infrastructure for healthcare organizations to measure patient outcomes, predict health trajectories, and accelerate medical research using real-world clinical data.
AI & Machine LearningData & InfrastructureHealthtechMedical DevicesBoston, US
Richard Gliklich, MD(Founder)Richard E. Gliklich(Executive Officer, Director)Richard Gliklich(Founder)
BoardRory O'Driscoll(Director)inLarry Bohn(Director)David Barrett(Director)
Co-investorsBreyer CapitalCorewell Health VenturesGeneral CatalystM33 GrowthScale Venture PartnersPolaris Partners
.png)
Zerigo Health develops technology-driven digital therapeutics and care solutions for individuals living with chronic skin conditions.
Digital HealthHealthtechMedical Devices
Co-investorsCorewell Health VenturesGeneral CatalystH.I.G. CapitalH.I.G. HealthBridge PartnersSV Health InvestorsAccel+3 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.